Advertisement
GOSS vs ONC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and ONC is a Hold.
GOSS's RSI Oscillator leaves overbought zone
The 10-day RSI Oscillator for GOSS moved out of overbought territory on September 10, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In 30 of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GOSS as a result. In 66 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
GOSS moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for GOSS crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GOSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for GOSS just turned positive on October 12, 2026. Looking at past instances where GOSS's MACD turned positive, the stock continued to rise in 35 of 40 cases over the following month. The odds of a continued upward trend are 88%.
The 50-day moving average for GOSS moved above the 200-day moving average on September 18, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where GOSS advanced for three days, in 214 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
GOSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.666) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. GOSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GOSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for ONC turns positive, indicating new upward trend
ONC saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In 61 of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ONC just turned positive on October 16, 2026. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.
ONC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
ONC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 196 of 260 cases where ONC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ONC crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.026) is normal, around the industry mean (26.782). P/E Ratio (65.653) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.776) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (6.553) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
GOSS | ONC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 58 | |
PRICE GROWTH RATING 1..100 | 91 | 40 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GOSS's Valuation (48) in the Pharmaceuticals Major industry is somewhat better than the same rating for ONC (88) in the Biotechnology industry. This means that GOSS’s stock grew somewhat faster than ONC’s over the last 12 months.
GOSS's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ONC (100) in the Biotechnology industry. This means that GOSS’s stock grew similarly to ONC’s over the last 12 months.
ONC's SMR Rating (58) in the Biotechnology industry is somewhat better than the same rating for GOSS (100) in the Pharmaceuticals Major industry. This means that ONC’s stock grew somewhat faster than GOSS’s over the last 12 months.
ONC's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for GOSS (91) in the Pharmaceuticals Major industry. This means that ONC’s stock grew somewhat faster than GOSS’s over the last 12 months.
ONC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that ONC’s stock grew similarly to GOSS’s over the last 12 months.
| GOSS | ONC | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 90% | N/A |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| Advances ODDS (%) | 17 days ago 84% | 2 days ago 74% |
| Declines ODDS (%) | 1 day ago 89% | 4 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| Aroon ODDS (%) | N/A | 1 day ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GOSS’s FA Score shows that 0 FA rating(s) are green while ONC’s FA Score has 0 green FA rating(s).
- GOSS’s FA Score: 0 green, 5 red.
- ONC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GOSS’s TA Score shows that 5 TA indicator(s) are bullish while ONC’s TA Score has 6 bullish TA indicator(s).
- GOSS’s TA Score: 5 bullish, 5 bearish.
- ONC’s TA Score: 6 bullish, 3 bearish.
Price Growth
GOSS (@Biotechnology) experienced а -5.80% price change this week, while ONC (@Biotechnology) price change was +4.12% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
GOSS is expected to report earnings on Nov 05, 2026.
ONC is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HFMF | 22.73 | 0.21 | +0.93% |
| Unlimited HFMF Managed Futures ETF (HFMF) | |||
| EQIN | 54.12 | 0.35 | +0.64% |
| Columbia U.S. Equity Income ETF (EQIN) | |||
| GLBL | 28.73 | N/A | N/A |
| Pacer MSCI World Industry Advantage ETF | |||
| FYX | 134.28 | -1.70 | -1.25% |
| First Trust Small Cap Core Alphadex Fund (FYX) | |||
| AFGR | 36.84 | -0.88 | -2.33% |
| First Trust Active Factor Large Cap Growth ETF (AFGR) | |||
ONC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ONC has been loosely correlated with HALO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then HALO could also see price increases.
| Ticker / NAME | Correlation To ONC | 1D Price Change % | ||
|---|---|---|---|---|
| ONC | 100% | -1.34% | ||
| HALO - ONC | 39% Loosely correlated | +0.27% | ||
| AXON - ONC | 37% Loosely correlated | -6.45% | ||
| VRTX - ONC | 37% Loosely correlated | -1.77% | ||
| GOSS - ONC | 35% Loosely correlated | -1.35% | ||
| ABEO - ONC | 34% Loosely correlated | -4.73% | ||
More | ||||